Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies.

This research presents a study on equine arteritis virus (EAV) infection in ponies and the detection methods for cytotoxic T lymphocyte precursors in the peripheral blood, contributing to a better understanding of EAV virus clearance in horses.

Study Overview

• The study focuses on EAV, a virus that causes systemic infections in horses with diverse outcomes, such as subclinical infections, severe disease, or even inducing abortion in pregnant mares or persistent infections in male horses.
• This research was undertaken due to the limited understanding of cellular immunity against EAV, mostly brought about by the lack of methods to evaluate these immune responses.
• The present study explores and elucidates new methods of detecting cytotoxic T lymphocyte (CTL) precursors in the blood of convalescent ponies using a (51)Cr release cytolysis assay.

Methodology and Observations

• The researchers employed primary equine dermal cells as CTL targets, demonstrating that these cells express MHC I but not MHC II and efficiently retain (51)Cr while also supporting EAV replication.
• They collected peripheral blood mononuclear cells (PBMC) from EAV-convalescent ponies and incubated them with or without the live EAV virus.
• The PBMC cultures induced by EAV showed evidence of expanding and activating lymphoblasts, with observable increases in the CD8(+)/CD4(+) ratio compared to those induced by the mock virus. This indicated that the cytotoxicity was initiated by EAV-stimulated PBMC.
• This discovered cytotoxicity was evidenced to be virus-specific, genetically restricted, and mediated by CD8(+) T lymphocytes. It could also be detected from 4 months to over a year post-infection.

Significance of the Study

• The results and methods derived from this study are anticipated to contribute to a better comprehension of virus-host interactions in horses, particularly the mechanisms behind virus clearance during EAV infection.
• It also opens up new avenues for further research into the cellular immunity exhibited in horses against EAV, which could lead to better diagnostic methods or treatments.